Exclusive: Lithuanian biotech Atrandi Biosciences raises $25M Series Anews2025-02-18T12:00:36+00:00February 18th, 2025|Endpoints News|
Pain biotech Latigo eyes up to $150M raise following Vertex’s landmark FDA nodnews2025-02-18T11:30:40+00:00February 18th, 2025|Endpoints News|
Kojin Therapeutics shuts down, citing lack of investor interest and complex sciencenews2025-02-14T16:25:49+00:00February 14th, 2025|Endpoints News|
Hunger-suppressing biotech Aardvark raises $94M in IPOnews2025-02-13T10:13:30+00:00February 13th, 2025|Endpoints News|
Roche sends experimental CNS drugs to Newleos, a new biotech backed with $93.5Mnews2025-02-13T05:00:31+00:00February 13th, 2025|Endpoints News|
After passing on M&A offers, Abcuro raises $200M in bid to become commercial drugmakernews2025-02-12T12:00:32+00:00February 12th, 2025|Endpoints News|
Sionna inks $191M IPO for cystic fibrosis pipeline as Aardvark eyes $89M for its own listingnews2025-02-07T11:27:13+00:00February 7th, 2025|Endpoints News|
Acelyrin and Alumis to merge in deal combining cash, assetsnews2025-02-06T23:07:11+00:00February 6th, 2025|Endpoints News|
With first drug now in the clinic, Alys eyes megaround for rest of pipelinenews2025-02-05T16:14:41+00:00February 5th, 2025|Endpoints News|
How opioid addiction treatment startup Bicycle Health reached a profitnews2025-02-04T14:47:38+00:00February 4th, 2025|Endpoints News|
